Search

…but also in reducing costs via improved decision making, leveling the playing field between small startups and established pharmaceutical companies. Our vision is that this improved efficiency and competition will…

…at a scale sufficient to test and train models is a major limitation in the integration of machine learning and antibody discovery. We will present the use of high throughput…

…measured on the LSAXT as compared to the Biacore 8K. Figure 2. Significant reduction in resources required to perform FcγR characterization on the LSAXT as compared with the Biacore 8K….

…platform companies. As CEO of ForteBio, Inc., he established product development and commercial strategies that resulted in its rapid growth and acquisition by Pall Corporation. During his nine-year tenure as…

…Binning Classical Epitope Binning In epitope binning, antibodies are tested in a pairwise combinatorial manner, and those that compete for the same binding region are grouped together into bins. In…

…lead compounds. While a huge benefit to DEL technology is its reduction in the sheer number and tracking of discrete compounds through the screening process, it does come with a…

Discovery on Target 2023 – Boston…

…the need to label components, robust and quantitative direct measures can be made for selectivity, binary affinity, ternary affinity, and cooperativity. In this approach, a comprehensive view of each PROTAC…

…capability to conduct potency assays on the LSA highlights new opportunities for leveraging high-throughput surface plasmon resonance (HT-SPR) in drug discovery and development Overview Potency assays have wide applicability in…